AXS Investments LLC Trims Stock Holdings in Global Medical REIT Inc. (NYSE:GMRE)

AXS Investments LLC trimmed its holdings in Global Medical REIT Inc. (NYSE:GMRE) by 15.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,319 shares of the company’s stock after selling 15,353 shares during the period. AXS Investments LLC owned approximately 0.13% of Global Medical REIT worth $779,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of GMRE. JPMorgan Chase & Co. boosted its holdings in Global Medical REIT by 6.4% in the 1st quarter. JPMorgan Chase & Co. now owns 728,295 shares of the company’s stock valued at $11,886,000 after purchasing an additional 43,687 shares during the period. Raymond James & Associates boosted its holdings in Global Medical REIT by 12.9% in the 1st quarter. Raymond James & Associates now owns 136,298 shares of the company’s stock valued at $2,224,000 after purchasing an additional 15,528 shares during the period. MetLife Investment Management LLC boosted its holdings in Global Medical REIT by 58.8% in the 1st quarter. MetLife Investment Management LLC now owns 29,210 shares of the company’s stock valued at $477,000 after purchasing an additional 10,812 shares during the period. Great West Life Assurance Co. Can boosted its holdings in Global Medical REIT by 6.3% in the 1st quarter. Great West Life Assurance Co. Can now owns 52,268 shares of the company’s stock valued at $886,000 after purchasing an additional 3,089 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in Global Medical REIT by 0.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 755,453 shares of the company’s stock valued at $12,329,000 after purchasing an additional 5,087 shares during the period. 56.46% of the stock is currently owned by hedge funds and other institutional investors.

Global Medical REIT Stock Performance

NYSE GMRE opened at $9.73 on Friday. Global Medical REIT Inc. has a 52-week low of $8.04 and a 52-week high of $11.79. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.11 and a current ratio of 0.11. The company has a market capitalization of $637.95 million, a P/E ratio of 38.92 and a beta of 1.09. The company has a fifty day moving average of $9.07 and a 200-day moving average of $9.24.

Global Medical REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 10th. Stockholders of record on Friday, September 22nd were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 8.63%. The ex-dividend date of this dividend was Thursday, September 21st. Global Medical REIT’s dividend payout ratio is currently 336.00%.

Wall Street Analyst Weigh In

Several brokerages have commented on GMRE. StockNews.com raised shares of Global Medical REIT from a “hold” rating to a “buy” rating in a report on Friday, November 10th. Compass Point lifted their price objective on shares of Global Medical REIT from $11.00 to $12.50 in a report on Friday, August 4th.

Global Medical REIT Company Profile

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.